Katarzyna Kuter, PhD
Department of Neuro- and Psychopharmacology
The main interest of my research is recognition of mechanisms active in preclinical stages of Parkinson’s Disease. There are both mechanisms leading to neuronal death as well as those compensating for deficits in brain dopaminergic system. Those opposite processes are active in brain at the same time and mask early disease symptoms. Therefore, reliable diagnosis at preclinical stages of Parkinson’s disease is very difficult and prevents from using neuroprotective and disease modifying strategies.Our studies in animal models focus on several aspects of brain functioning at the level of neural circuits, groups of cells, cellular organelles and particular proteins.
· Identification of mechanisms involved in compensation of dopaminergic neurons degeneration.
· Establishing the role of small, repeated oxidative stress in neurodegeneration - preconditioning.
· Protective role of glial cells and astrocyte – neuron cooperation in brain during compensation.
· Regulation of cellular energetics and substrate needs during different stages of degeneration and its compensation. Role of carbohydrates and fatty acids.
· Functioning of mitochondria and regulation of composition and activity of respiratory oxphos complexes and supercomplexes.
· Mitochondrial membrane functioning in different cell states.
KEYWORDS: neurodegeneration, compensation, early Parkinson's disease, animal models, glia, dopaminergic system, energetic regulation, mitochondrial proteins
Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Katarzyna Kuter, Łukasz Olech, Urszula Głowacka
Molecular neurobiology, 10.1007/s12035-017-0529-z
Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
Katarzyna Kuter, Manuela Kratochwil, Sven-Hendric Marx, Sonja Hartwig, Stephan Lehr, Michiru D Sugawa, Norbert A Dencher
Archives of physiology and biochemistry,
Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease.
Katarzyna Kuter, Manuela Kratochwil, Klemencja Berghauzen-Maciejewska, Urszula Głowacka, Michiru D Sugawa, Krystyna Ossowska, Norbert A Dencher
Biochimica et biophysica acta, S0925-4439(16)30025-4 10.1016/j.bbadis.2016.01.022
Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
Klemencja Berghauzen-Maciejewska, Jadwiga Wardas, Barbara Kosmowska, Urszula Głowacka, Katarzyna Kuter, Krystyna Ossowska
PloS one, 10.1371/journal.pone.0117698
Pramipexole but not imipramine or fluoxetine reverses the
Klemencja Berghauzen-Maciejewska, Katarzyna Kuter, Wacław Kolasiewicz, Urszula Głowacka, Anna Dziubina, Krystyna Ossowska, Jadwiga Wardas
Behavioural brain research, 10.1016/j.bbr.2014.06.029 S0166-4328(14)00403-3
- 2013-09-02 - 2016-03-31
“MOBILNOSC PLUS” scholarship sponsored by Polish Ministry of Science and Higher Education.
Title: „Protective role of astrocytes in the process of neurodegeneration of dopaminergic cells and during functional compensation of this process. Analysis of function and architecture of mitochondrial oxphos complexes and supercomplexes in animal models of early Morbus Parkinson.”
Performed during three 6 month visits at Technische Universität Darmstadt, Darmstadt, Germany in group of Prof. Norbert A. Dencher.
NCN grant, OPUS 3 - 2013-02-14 - 2017-02-15
OPUS 3 grant nr 2012/05/B/NZ4/02599 financed by National Science Centre (NCN).
Title: „The role of astrocytes and cellular metabolism in functional compensation of degeneration of dopaminergic system in threats brain. Analysis of expression of AMPK and energy sensing proteins in aspect of Parkinson's disease.”
Performed in the Institute of Pharmacology, Polish Academy of Sciences – project leader.
- * Germany, Philipps-Universitaet Marburg, Institut fuer Pharmakologie und Klinische Pharmazie
- * Germany, Technische Universität Darmstadt, Clemens-Schöpf-Institut für Organische Chemie und Biochemie